RESUMEN
We examine the quantum structure of continuum entanglement and in the context of short-pulse down-conversion we answer the open question of how many of the uncountably many frequency modes contribute effectively to the entanglement. We derive a set of two-photon mode functions that provide an exact, discrete, and effectively finite basis for characterizing pairwise entanglement. Our analysis provides a basis for entropy control in two-photon pulses generated from down-conversion.
RESUMEN
We present an exact analytic solution of a nonlinear Schrodinger field interacting with a moving potential (obstacle) at supersonic speed. We discover conditions under which the field can form a stable shape-invariant structure localized around the obstacle-a dressing effect that protects the field against excitations by the obstacle. Such an effect demonstrates the existence of frictionless motion beyond the conventionally defined critical velocity.
RESUMEN
Contrast enhanced computed tomography (CECT) has been used for delineation of treatment target in radiotherapy. The different Hounsfield unit due to the injected contrast agent may affect radiation dose calculation. We investigated this effect on intensity modulated radiotherapy (IMRT) of nasopharyngeal carcinoma (NPC). Dose distributions of 15 IMRT plans were recalculated on CECT. Dose statistics for organs at risk (OAR) and treatment targets were recorded for the plain CT-calculated and CECT-calculated plans. Statistical significance of the differences was evaluated. Correlations were also tested, among magnitude of calculated dose difference, tumor size and level of enhancement contrast. Differences in nodal mean/median dose were statistically significant, but small (approximately 0.15 Gy for a 66 Gy prescription). In the vicinity of the carotid arteries, the difference in calculated dose was also statistically significant, but only with a mean of approximately 0.2 Gy. We did not observe any significant correlation between the difference in the calculated dose and the tumor size or level of enhancement. The results implied that the calculated dose difference was clinically insignificant and may be acceptable for IMRT planning.